Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             59 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Alemtuzumab outcomes by age: Post hoc analysis from the randomized CARE-MS studies over 8 years Bass, Ann D.

49 C p.
artikel
2 Anti-MOG antibody associated encephalomyelitis in an HIV-infected patient Mbonde, Amir A.

49 C p.
artikel
3 A quick assessment of reliable change in fatigue: Reliable change indices of the modified fatigue impact scale – 5 item (MFIS-5) Cozart, J.S.

49 C p.
artikel
4 Assessing the consistency and validity of self-reported year of diagnosis among participants in a longitudinal study of people with multiple sclerosis Claflin, Suzi B.

49 C p.
artikel
5 B cell therapy and the use of RNA-based COVID-19 vaccines Vishnevetsky, Anastasia

49 C p.
artikel
6 Brief international cognitive assessment for multiple sclerosis (BICAMS) cut-off scores for detecting cognitive impairment in multiple sclerosis Artemiadis, Artemios

49 C p.
artikel
7 Cancer diagnosis in a Spanish cohort of multiple sclerosis patients under dimethylfumarate treatment Gómez-Moreno, Mayra

49 C p.
artikel
8 Cladribine tablets versus other disease-modifying oral drugs in achieving no evidence of disease activity (NEDA) in multiple sclerosis–A systematic review and network meta-analysis Bartosik-Psujek, Halina

49 C p.
artikel
9 Comparison of the Efficacy and Safety of Anti-CD20 B Cells Depleting Drugs in Multiple Sclerosis Cotchett, Kelly R.

49 C p.
artikel
10 Co-occurrence of chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids and posterior reversible encephalopathy syndrome: a case report Song, Yanna

49 C p.
artikel
11 COVID-19 in ocrelizumab-treated people with multiple sclerosis Hughes, Richard

49 C p.
artikel
12 COVID-19 with no antibody response in a multiple sclerosis patient treated with cladribine: Implication for vaccination program? Gelibter, Stefano

49 C p.
artikel
13 Demographic features, behavioral measures, and clinical factors as predictors of cognitive function in patients with multiple sclerosis Alirezaei, Mohammad

49 C p.
artikel
14 Developing a clinical pathway to identify and manage cognitive problems in Multiple Sclerosis: Qualitative findings from patients, family members, charity volunteers, clinicians and healthcare commissioners Smith, Laura

49 C p.
artikel
15 Development of SARS-CoV-2 IgM and IgG antibodies in a relapsing multiple sclerosis patient on ofatumumab Flores-Gonzalez, Ramon E

49 C p.
artikel
16 Differential patterns of parafoveal and peripapillary vessel density in multiple sclerosis and neuromyelitis optica spectrum disorder Lee, Ga-In

49 C p.
artikel
17 Diffusely appearing white matter in multiple sclerosis: Insights from sodium (23Na) MRI Weber, Claudia E.

49 C p.
artikel
18 Disability and its association with psychological factors in multiple sclerosis patients Mohaghegh, Fahimeh

49 C p.
artikel
19 Disability measurement in Multiple Sclerosis patients 55 years and older: What is the Expanded Disability Status Scale really telling clinicians? Lynch, Sharon

49 C p.
artikel
20 Does cognitive training improve attention/working memory in persons with MS? A pilot study using the Cogmed Working Memory Training program Blair, Mervin

49 C p.
artikel
21 Dual task training effects on gait and balance outcomes in multiple sclerosis: A systematic review Morelli, Nathan

49 C p.
artikel
22 Effect of inosine monophosphate dehydrogenase-1 gene polymorphisms on mycophenolate mofetil effectiveness in neuromyelitis optica spectrum disorder patients Liu, Lanzhi

49 C p.
artikel
23 Elevated cerebrospinal fluid β2-microglobulin levels in patients with neuromyelitis optica spectrum disorders Zhang, Lin-Jie

49 C p.
artikel
24 ELTD1 as a biomarker for multiple sclerosis: Pre-clinical molecular-targeted studies in a mouse experimental autoimmune encephalomyelitis model Towner, Rheal A.

49 C p.
artikel
25 Event-related potentials and deep grey matter atrophy in multiple sclerosis: Exploring the possible associations with cognition Lorefice, L.

49 C p.
artikel
26 Fever is a common onset feature of MOG-IgG associated disorders (MOGAD) Lampros, Alexandre

49 C p.
artikel
27 “FLAMES: A novel burning entity in MOG IgG associated disease” Jain, Kshiteeja

49 C p.
artikel
28 Geography of hospital admissions for multiple sclerosis in Greece Dadouli, Katerina

49 C p.
artikel
29 Improving MS patients’ understanding of treatment risks and benefits in clinical consultations: A randomised crossover trial Reen, Gurpreet K

49 C p.
artikel
30 Living with severe multiple sclerosis: Cost-effectiveness of a palliative care intervention and cost of illness study Rosato, Rosalba

49 C p.
artikel
31 Lower lymphocyte counts and older age are associated with reduced multiple sclerosis disease activity during dimethyl fumarate treatment Garbo, Riccardo

49 C p.
artikel
32 MAGNIMS score predicts long-term clinical disease activity-free status and confirmed disability progression in patients treated with subcutaneous interferon beta-1a Sormani, Maria Pia

49 C p.
artikel
33 Mental symptoms in MS (MeSyMS): Development and validation of a new assessment Filser, Melanie

49 C p.
artikel
34 Multiple Sclerosis does not affect the muscular strength of the pelvic floor during pregnancy a case control study. Lourenço, Gisele Alexandre

49 C p.
artikel
35 Ocrelizumab depletes T-lymphocytes more than rituximab in multiple sclerosis Capasso, Nicola

49 C p.
artikel
36 Optimal management of neuromyelitis optica spectrum disorder with aquaporin-4 antibody by oral prednisolone maintenance therapy Takai, Yoshiki

49 C p.
artikel
37 Pandemic forward: Lessons learned and expert perspectives on multiple sclerosis care in the COVID-19 era Nicholas, Jacqueline A.

49 C p.
artikel
38 Para-infectious anti-GD2/GD3 IgM myelitis during the Covid-19 pandemic: Case report and literature review Rodríguez de Antonio, Luis Alberto

49 C p.
artikel
39 Perilesional neurodegenerative injury in multiple sclerosis: Relation to focal lesions and impact on disability Clarke, Margareta A.

49 C p.
artikel
40 Periodized versus classic exercise therapy in Multiple Sclerosis: a randomized controlled trial Keytsman, Charly

49 C p.
artikel
41 Physical Activity in Youth with Multiple Sclerosis receiving the ATOMIC intervention: Social connectedness above all else Ly, Mina

49 C p.
artikel
42 Predicting conversion to multiple sclerosis by assessing cognitive impairment in radiologically isolated syndrome Domingo-Santos, Ángela

49 C p.
artikel
43 Predicting falls and injuries in people with multiple sclerosis using machine learning algorithms Piryonesi, S. Madeh

49 C p.
artikel
44 Prevalence and determinants of falls in persons with multiple sclerosis without a clinical disability Abasıyanık, Zuhal

49 C p.
artikel
45 Primary mediastinal large B-cell lymphoma in a patient on Fingolimod for relapsing-remitting multiple sclerosis Chacko, Joseph A

49 C p.
artikel
46 Safety of disease-modifying treatments in SARS-CoV-2 antibody-positive multiple sclerosis patients Mallucci, Giulia

49 C p.
artikel
47 Seasonal patterns of relapse and disability in Danish MS patients: A population-based cohort study Elser, Holly C.

49 C p.
artikel
48 Self-reported use of vitamin D supplements is associated with higher physical quality of life scores in multiple sclerosis Simpson-Yap, Steve

49 C p.
artikel
49 Simultaneous bilateral optic neuropathy and myelitis revealing paraneoplastic neurological syndrome associated with multiple onconeuronal antibodies Carette, Timothée

49 C p.
artikel
50 Speech Pathology-Specific Questionnaire for Persons with Multiple Sclerosis (SMS): adaptation, validation and preliminary assessment of the diagnostic potential. Morawska, Joanna

49 C p.
artikel
51 Subgroup analysis of clinical and MRI outcomes in participants with a first clinical demyelinating event at risk of multiple sclerosis in the ORACLE-MS study Cree, Bruce A.C.

49 C p.
artikel
52 Superlative use within news articles relating to therapies for multiple sclerosis Ferrell, Matthew

49 C p.
artikel
53 The influence of smoking on the pattern of disability and relapse risk in AQP4-positive Neuromyelitis Optica Spectrum Disorder, MOG-Ab Disease and Multiple Sclerosis Messina, Silvia

49 C p.
artikel
54 The prevalence of cognitive impairment in patients with neuromyelitis optica spectrum disorders (NMOSD): A systematic review and meta-analysis Moghadasi, Abdorreza Naser

49 C p.
artikel
55 Useless hand syndrome: Diagnostic role of electromyography and nerve conduction studies Shields, Lisa B.E.

49 C p.
artikel
56 Use of a claims-based algorithm to estimate disease severity in the multiple sclerosis Medicare population Toliver, Joshua C.

49 C p.
artikel
57 What percentage of AQP4-ab-negative NMOSD patients are MOG-ab positive? A study from the Argentinean multiple sclerosis registry (RelevarEM) Carnero Contentti, Edgar

49 C p.
artikel
58 Willingness to obtain COVID-19 vaccination in adults with multiple sclerosis in the United States Ehde, Dawn M.

49 C p.
artikel
59 Working capacity level of patients with multiple sclerosis in Lithuania: Its dynamics and relationship with the employment and lethal outcomes Valadkeviciene, Daiva

49 C p.
artikel
                             59 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland